| D00126 |
Ibuprofen (JP18/USP/INN); Advil (TN); Motrin (TN) |
(P) CYP inhibition: CYP2C9 |
| D00127 |
Piroxicam (JP18/USP/INN); Feldene (TN) |
(P) CYP inhibition: CYP2C9 |
| D00142 |
Methotrexate (JP18/USP/INN); Otrexup (TN); Xatmep (TN) |
(P) unclassified |
| D00151 |
Mefenamic acid (JP18/USP/INN); Ponstel (TN) |
(P) CYP inhibition: CYP2C9 |
| D00255 |
Carvedilol (JP18/USP/INN); Artist (TN); Coreg (TN) |
(P) CYP inhibition: CYP2C9 |
| D00287 |
Cyclophosphamide (USP); Cyclophosphamide hydrate (JP18); Cytoxan (TN); Neosar (TN) |
(P) CYP inhibition: CYP2C9 |
| D00326 |
Fluoxetine (USAN/INN); Fluoxetine (TN) |
(P) CYP inhibition: CYP2C9 |
| D00330 |
Flurbiprofen (JP18/USP/INN); Ansaid (TN) |
(P) CYP inhibition: CYP2C9 |
| D00331 |
Furosemide (JP18/USP/INN); Frusemide; Lasix (TN) |
(P) Transporter inhibition: SLC22A6 SLC22A8 |
| D00336 |
Glyburide (USP); Glibenclamide (JP18/INN); Diabeta (TN); Glynase (TN); Micronase (TN) |
(P) CYP inhibition: CYP2C9 |
| D00357 |
Losartan potassium (JP18/USP); Cozaar (TN) |
(P) CYP inhibition: CYP2C9 |
| D00382 |
Torsemide (USP); Torasemide (JAN/INN); Demadex (TN); Luprac (TN) |
(P) CYP inhibition: CYP2C9 |
| D00400 |
Valsartan (JP18/USP/INN); Diovan (TN) |
(P) CYP inhibition: CYP2C9 |
| D00452 |
Suprofen (JAN/USP/INN); Profenal (TN) |
(P) CYP inhibition: CYP2C9 |
| D00457 |
Quazepam (JAN/USP/INN); Doral (TN) |
(P) CYP inhibition: CYP2C9 |
| D00512 |
Phenytoin (JP18/USP/INN); Dilantin (TN) |
(P) CYP inhibition: CYP2C9 |
| D00522 |
Candesartan (USAN/INN) |
(P) CYP inhibition: CYP2C9 |
| D00523 |
Irbesartan (JP18/USP/INN); Avapro (TN) |
(P) CYP inhibition: CYP2C9 |
| D00529 |
Montelukast sodium (JP18/USP); Singulair (TN) |
(P) CYP inhibition: CYP2C9 |
| D00564 |
Warfarin sodium (USP); Coumadin (TN); Jantoven (TN) |
(P) CYP inhibition: CYP2C9 |
| D00567 |
Celecoxib (JP18/USP/INN); Celebrex (TN); Onsenal (TN) |
(P) CYP inhibition: CYP2C9 |
| D00593 |
Glimepiride (JP18/USP/INN); Amaryl (TN) |
(P) CYP inhibition: CYP2C9 |
| D00626 |
Candesartan cilexetil (JP18/USP); Atacand (TN) |
(P) CYP inhibition: CYP2C9 |
| D00631 |
Bepridil hydrochloride (USAN); Bepridil hydrochloride hydrate (JAN); Vascor (TN) |
(P) CYP inhibition: CYP2C9 |
| D00653 |
Dorzolamide hydrochloride (JP18/USP); Trusopt (TN) |
(P) CYP inhibition: CYP2C9 |
| D00674 |
Naratriptan hydrochloride (JAN/USP); Amerge (TN) |
(P) CYP inhibition: CYP2C9 |
| D00706 |
Zolpidem tartrate (JP18/USP); Ambien (TN); Intermezzo (TN) |
(P) unclassified |
| D00814 |
Doxepin hydrochloride (USP); Sinequan (TN); Zonalon (TN) |
(P) CYP inhibition: CYP2C9 |
| D00823 |
Fluoxetine hydrochloride (JAN/USP); Prozac (TN); Sarafem (TN) |
(P) CYP inhibition: CYP2C9 |
| D00825 |
Sertraline hydrochloride (JAN/USP); Zoloft (TN) |
(P) CYP inhibition: CYP2C9 |
| D00892 |
Fluvastatin sodium (JAN/USP); Lescol (TN) |
(P) CYP inhibition: CYP2C9 |
| D00903 |
Diclofenac potassium (USP); Cambia (TN); Cataflam (TN); Zipsor (TN) |
(P) CYP inhibition: CYP2C9 |
| D00904 |
Diclofenac sodium (JP18/USP); Solaraze (TN); Voltaren (TN) |
(P) CYP inhibition: CYP2C9 |
| D00969 |
Meloxicam (JAN/USP/INN); Mobic (TN) |
(P) CYP inhibition: CYP2C9 |
| D01056 |
Benzbromarone (JP18/USAN/INN); Uroleap (TN) |
(P) CYP inhibition: CYP2C9 |
| D01111 |
Nateglinide (JP18/USP/INN); Starsis (TN) |
(P) CYP inhibition: CYP2C9 |
| D01122 |
Ibuprofen piconol (JP18/USAN); Staderm (TN) |
(P) CYP inhibition: CYP2C9 |
| D01223 |
Capecitabine (JAN/USP/INN); Xeloda (TN) |
(P) CYP inhibition: CYP2C9 |
| D01227 |
Bosentan (USAN); Bosentan hydrate (JAN); Tracleer (TN) |
(P) CYP inhibition: CYP2C9 |
| D01280 |
Warfarin potassium (JP18); Athrombin-K (TN) |
(P) CYP inhibition: CYP2C9 |
| D01397 |
Ampiroxicam (JP18/INN); Flucam (TN) |
(P) CYP inhibition: CYP2C9 |
| D01475 |
Flurbiprofen axetil (JAN); FP 83; Ropion (TN) |
(P) CYP inhibition: CYP2C9 |
| D01514 |
Etizolam (JP18/INN); Sedekopan (TN) |
(P) CYP inhibition: CYP2C9 |
| D01583 |
Pirfenidone (JAN/USAN/INN); Esbriet (TN) |
(P) unclassified |
| D01624 |
Sarpogrelate hydrochloride (JP18); Anplag (TN) |
(P) CYP inhibition: CYP2C9 |
| D01718 |
Mofezolac (JAN/INN); Mofezolac (TN) |
(P) CYP inhibition: CYP2C9 |
| D01767 |
Tenoxicam (JAN/USAN/INN); Tilcotil (TN) |
(P) CYP inhibition: CYP2C9 |
| D01862 |
Pitavastatin calcium (JAN); NK 104; Livalo (TN) |
(P) CYP inhibition: CYP2C9 |
| D01866 |
Lornoxicam (JP18/USAN/INN); Lorcam (TN) |
(P) CYP inhibition: CYP2C9 |
| D02027 |
Tranilast (JP18/USAN/INN); Rizaben (TN) |
(P) CYP inhibition: CYP2C9 |
| D02096 |
Fosphenytoin sodium (USP); Cerebyx (TN); Sesquient (TN) |
(P) CYP inhibition: CYP2C9 |
| D02102 |
Methadone hydrochloride (JAN/USP); Dolophine hydrochloride (TN) |
(P) CYP inhibition: CYP2C9 |
| D02103 |
Phenytoin sodium (USP); Phenytoin sodium for injection (JP18); Aleviatin (TN); Dilantin (TN) |
(P) CYP inhibition: CYP2C9 |
| D02115 |
Methotrexate sodium; Trexall (TN); Rasuvo (TN) |
(P) unclassified |
| D02219 |
Terbinafine hydrochloride (JP18/USP); Lamisil (TN) |
(P) CYP inhibition: CYP2C9 |
| D02229 |
Sildenafil citrate (JAN/USP); Revatio (TN); Viagra (TN) |
(P) unclassified |
| D02290 |
Flurbiprofen sodium (USP); Ocufen (TN) |
(P) CYP inhibition: CYP2C9 |
| D02360 |
Sertraline (INN) |
(P) CYP inhibition: CYP2C9 |
| D02375 |
Terbinafine (USAN/INN); Lamasil (TN) |
(P) CYP inhibition: CYP2C9 |
| D02689 |
Ramelteon (JAN/USAN/INN); Rozerem (TN) |
(P) unclassified |
| D02829 |
Alosetron hydrochloride (USAN); Lotrpnex (TN) |
(P) CYP inhibition: CYP2C9 |
| D03415 |
Carvedilol phosphate (USAN); Carvedilol phosphate hydrate (JAN); Coreg CR (TN) |
(P) CYP inhibition: CYP2C9 |
| D03844 |
Phenytoin, phenobarbital and caffeine and sodium benzoate; Hydantol F (TN) |
(P) CYP inhibition: CYP2C9 |
| D04112 |
Etravirine (JAN/USAN/INN); Intelence (TN) |
(P) CYP inhibition: CYP2C9 |
| D04148 |
Fenfluramine hydrochloride (JAN/USAN); Fintepla (TN); Pondimin (TN) |
(P) unclassified |
| D04463 |
Norgestrel and ethinylestradiol tablets (JP18); Low-ogestrel (TN); Planovar (TN) |
(P) CYP inhibition: CYP2C9 |
| D04484 |
Desogestrel and ethinylestradiol; Marvelon21 (TN); Ortho-cept (TN) |
(P) CYP inhibition: CYP2C9 |
| D04490 |
Ibuprofen aluminum (USAN) |
(P) CYP inhibition: CYP2C9 |
| D05511 |
Piroxicam betadex (USAN) |
(P) CYP inhibition: CYP2C9 |
| D05512 |
Piroxicam cinnamate (USAN) |
(P) CYP inhibition: CYP2C9 |
| D05513 |
Piroxicam olamine (USAN) |
(P) CYP inhibition: CYP2C9 |
| D06606 |
Ibuprofen lysine (USAN); Ibuprofen L-lysine (JAN); Solufenum; Neoprofen (TN) |
(P) CYP inhibition: CYP2C9 |
| D07129 |
Alosetron (INN) |
(P) CYP inhibition: CYP2C9 |
| D07283 |
Esketamine (USAN/INN) |
(P) unclassified |
| D07299 |
Lacosamide (JAN/USAN/INN); Erlosamide; Vimpat (TN) |
(P) CYP inhibition: CYP2C9 |
| D07520 |
Bepridil (INN); Bepadin (TN) |
(P) CYP inhibition: CYP2C9 |
| D07538 |
Bosentan (INN) |
(P) CYP inhibition: CYP2C9 |
| D07583 |
Phenytoin and phenobarbital; Aleviatin with phenobarbital (TN) |
(P) CYP inhibition: CYP2C9 |
| D07595 |
Fosphenytoin sodium hydrate (JAN); Fostoin (TN) |
(P) CYP inhibition: CYP2C9 |
| D07760 |
Cyclophosphamide (INN); Cyclophosphamide (TN); Cytoxan (TN) |
(P) CYP inhibition: CYP2C9 |
| D07816 |
Diclofenac (USAN/INN); Solaraze (TN); Zorvolex (TN) |
(P) CYP inhibition: CYP2C9 |
| D07817 |
Diclofenac diethylamine; Voltaren Emulgel (TN) |
(P) CYP inhibition: CYP2C9 |
| D07818 |
Diclofenac epolamine; Diclofenac hydroxyethylpyrrolidine; Flector (TN) |
(P) CYP inhibition: CYP2C9 |
| D07819 |
Diclofenac calcium; Voltaren Actingo Extra (TN) |
(P) CYP inhibition: CYP2C9 |
| D07871 |
Dorzolamide (INN); Trusopt (TN) |
(P) CYP inhibition: CYP2C9 |
| D07875 |
Doxepin (INN); Sinequan (TN) |
(P) CYP inhibition: CYP2C9 |
| D07895 |
Losartan potassium and hydrochlorothiazide (JP18); Hydrochlorothiazide and losartan potassium; Hyzaar (TN); Losarhyd (TN) |
(P) CYP inhibition: CYP2C9 |
| D07945 |
Fenfluramine (INN); Ponderax (TN) |
(P) unclassified |
| D07983 |
Fluvastatin (INN); Fluvas (TN) |
(P) CYP inhibition: CYP2C9 |
| D07993 |
Fosphenytoin (INN) |
(P) CYP inhibition: CYP2C9 |
| D07999 |
Sodium furosemide; Frosemide sodium; Lasix (TN) |
(P) Transporter inhibition: SLC22A6 SLC22A8 |
| D08001 |
Furosemide diolamine; Furosemide diethanolamine salt; Nuriban (TN) |
(P) Transporter inhibition: SLC22A6 SLC22A8 |
| D08058 |
Ibuprofen arginine salt; Zafen (TN) |
(P) CYP inhibition: CYP2C9 |
| D08059 |
Ibuprofen sodium; Ibuprofen sodium anhydrous; Esprenit (TN) |
(P) CYP inhibition: CYP2C9 |
| D08146 |
Losartan (INN); Losartic (TN) |
(P) CYP inhibition: CYP2C9 |
| D08195 |
Methadone (BAN) |
(P) CYP inhibition: CYP2C9 |
| D08229 |
Montelukast (INN); Brondilat (TN) |
(P) CYP inhibition: CYP2C9 |
| D08255 |
Naratriptan (INN); Naramig (TN) |
(P) CYP inhibition: CYP2C9 |
| D08493 |
Dorzolamide hydrochloride and timolol maleate (JP18); Cosopt (TN) |
(P) CYP inhibition: CYP2C9 |
| D08508 |
Sarpogrelate (INN) |
(P) CYP inhibition: CYP2C9 |
| D08514 |
Sildenafil (INN); Aphrodil (TN) |
(P) unclassified |
| D08619 |
Torasemide sodium; Torem (TN) |
(P) CYP inhibition: CYP2C9 |
| D08682 |
Warfarin (INN); Warfarine; Choice (TN) |
(P) CYP inhibition: CYP2C9 |
| D08690 |
Zolpidem (INN); Sanval (TN) |
(P) unclassified |
| D08864 |
Azilsartan (JAN/USAN/INN); Azilva (TN) |
(P) CYP inhibition: CYP2C9 |
| D08870 |
Belinostat (USAN/INN); Beleodaq (TN) |
(P) CYP inhibition: CYP2C9 |
| D09666 |
Selumetinib (USAN/INN) |
(P) CYP inhibition: CYP2C9 |
| D09760 |
Ibuprofen sodium (USAN); Ibuprofen sodium hydrate |
(P) CYP inhibition: CYP2C9 |
| D09848 |
Pioglitazone hydrochloride and glimepiride tablets (JP18); Pioglitazone and glimepiride; Duetact; Sonias (TN) |
(P) CYP inhibition: CYP2C9 |
| D09921 |
Lesinurad (USAN/INN); Zurampic (TN) |
(P) CYP inhibition: CYP2C9 |
| D09922 |
Lesinurad sodium (USAN) |
(P) CYP inhibition: CYP2C9 |
| D09959 |
Ruxolitinib (USAN/INN) |
(P) unclassified |
| D09960 |
Ruxolitinib phosphate (JAN/USAN); Jakafi (TN); Jakavi (TN); Opzelura (TN) |
(P) unclassified |
| D10020 |
Olodaterol hydrochloride (JAN/USAN); Striverdi respimat (TN) |
(P) CYP inhibition: CYP2C9 |
| D10024 |
Selumetinib sulfate (JAN/USAN); Koselugo (TN) |
(P) CYP inhibition: CYP2C9 |
| D10145 |
Olodaterol (USAN/INN); Striverdi respimat (TN) |
(P) CYP inhibition: CYP2C9 |
| D10184 |
Vortioxetine (USAN); Brintellix (TN) |
(P) CYP inhibition: CYP2C9 |
| D10185 |
Vortioxetine hydrobromide (JAN/USAN); Brintellix (TN); Trintellix (TN) |
(P) CYP inhibition: CYP2C9 |
| D10254 |
Esflurbiprofen (JAN) |
(P) CYP inhibition: CYP2C9 |
| D10306 |
Avatrombopag (USAN/INN) |
(P) CYP inhibition: CYP2C9 |
| D10307 |
Avatrombopag maleate (JAN/USAN); Doptelet (TN) |
(P) CYP inhibition: CYP2C9 |
| D10308 |
Baricitinib (JAN/USAN/INN); Olumiant (TN) |
(P) Transporter inhibition: SLC22A8 |
| D10315 |
Momelotinib (USAN/INN) |
(P) CYP inhibition: CYP2C9 |
| D10358 |
Momelotinib dihydrochloride (USAN) |
(P) CYP inhibition: CYP2C9 |
| D10480 |
Irbesartan and trichlormethiazide; Irtra (TN) |
(P) CYP inhibition: CYP2C9 |
| D10512 |
Brinzolamide and timolol maleate; Azorga (TN) |
(P) CYP inhibition: CYP2C9 |
| D10568 |
Pitavastatin calcium hydrate (JP18); Pitabastatin calcium pentahydrate; Livalo (TN) |
(P) CYP inhibition: CYP2C9 |
| D10572 |
Fosnetupitant and palonosetron hydrochloride; Netupitant and palonosetron hydrochloride; Akynzeo (TN) |
(P) unclassified |
| D10627 |
Esketamine hydrochloride (JAN/USAN); Spravato (TN) |
(P) unclassified |
| D10662 |
Rimegepant (USAN/INN) |
(P) unclassified |
| D10663 |
Rimegepant sulfate (USAN); Rimegepant sulfate hydrate (JAN); Nurtec odt (TN); Vydura (TN) |
(P) unclassified |
| D10711 |
Pemafibrate (JAN); Parmodia (TN) |
(P) CYP inhibition: CYP2C9 |
| D10746 |
Esflurbiprofen and mentha oil; Loqoa (TN) |
(P) CYP inhibition: CYP2C9 |
| D10889 |
Momelotinib hydrochloride hydrate (JAN); Momelotinib dihydrochloride monohydrate; Ojjaara (TN); Omjjara (TN) |
(P) CYP inhibition: CYP2C9 |
| D10927 |
Erdafitinib (JAN/USAN/INN); Balversa (TN) |
(P) CYP inhibition: CYP2C9 |
| D10930 |
Etrasimod (USAN) |
(P) CYP inhibition: CYP2C9 |
| D10931 |
Etrasimod arginine (USAN); Etrasimod L-arginine (JAN); Velsipity (TN) |
(P) CYP inhibition: CYP2C9 |
| D10960 |
Nirogacestat (USAN/INN) |
(P) CYP inhibition: CYP2C9 |
| D11072 |
Siponimod fumarate (USAN); Siponimod fumaric acid (JAN); Mayzent (TN) |
(P) CYP inhibition: CYP2C9 |
| D11092 |
Pitavastatin magnesium; Zypitamag (TN) |
(P) CYP inhibition: CYP2C9 |
| D11330 |
Voxelotor (USAN); Oxbryta (TN) |
(P) CYP inhibition: CYP2C9 |
| D11400 |
Abrocitinib (JAN/USAN); Cibinqo (TN) |
(P) CYP inhibition: CYP2C9 |
| D11453 |
Nirogacestat hydrobromide (USAN); Ogsiveo (TN) |
(P) CYP inhibition: CYP2C9 |
| D11460 |
Siponimod (USAN/INN) |
(P) CYP inhibition: CYP2C9 |
| D11576 |
Naproxen and esomeprazole magnesium; Vimovo (TN) |
(P) CYP inhibition: CYP2C9 |
| D11671 |
Elacestrant (USAN/INN) |
(P) CYP inhibition: CYP2C9 |
| D11672 |
Elacestrant hydrochloride (USAN); Elacestrant dihydrochloride; Orserdu (TN) |
(P) CYP inhibition: CYP2C9 |
| D11834 |
Vorasidenib (USAN/INN) |
(P) CYP inhibition: CYP2C9 |
| D11835 |
Vorasidenib citrate (USAN); Vorasidenib citric acid hydrate (JAN); Voranigo (TN) |
(P) CYP inhibition: CYP2C9 |
| D11866 |
Deuruxolitinib (USAN) |
(P) CYP inhibition: CYP2C9 |
| D11867 |
Deuruxolitinib phosphate (USAN); Leqselvi (TN) |
(P) CYP inhibition: CYP2C9 |
| D11976 |
Fezolinetant (USAN); Veozah (TN) |
(P) unclassified |
| D11977 |
Fruquintinib (JAN/USAN); Fruzaqla (TN) |
(P) CYP inhibition: CYP2C9 |
| D12265 |
Mavacamten (JAN/USAN/INN); Camzyos (TN) |
(P) CYP inhibition: CYP2C9 |
| D12363 |
Taletrectinib (USAN/INN) |
(P) CYP inhibition: CYP2C9 |
| D12364 |
Taletrectinib adipate (JAN/USAN); Ibtrozi (TN) |
(P) CYP inhibition: CYP2C9 |
| D12544 |
Vortioxetine hemihydrobromide (USAN) |
(P) CYP inhibition: CYP2C9 |
| D12597 |
Ibuprofen trelamine (USAN); Ibuprofen diethylaminoethyl ester |
(P) CYP inhibition: CYP2C9 |
| D12598 |
Ibuprofen trelamine hydrochloride (USAN) |
(P) CYP inhibition: CYP2C9 |
| D12733 |
Dordaviprone (USAN/INN) |
(P) CYP inhibition: CYP2C9 |
| D12734 |
Dordaviprone hydrochloride (JAN/USAN); Dordaviprone dihydrochloride; Modeyso (TN) |
(P) CYP inhibition: CYP2C9 |
| D12756 |
Vonoprazan and amoxicillin; Voquezna (TN) |
(P) CYP inhibition: CYP2C9 |
| D12963 |
Macitentan and tadalafil; Opsynvi (TN); Yuvanci (TN) |
(P) CYP inhibition: CYP2C9 |
| D13120 |
Avutometinib and defactinib; Avmapki fakzynja (TN) |
(P) CYP inhibition: CYP2C9 |
